By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Modified Medical Research Council Questionnaire (of Dyspnea Scale) for COPD
Summary
What it measures:
Used to measure the degree of breathlessness related to activities.
Target Population:
People with chronic obstructive pulmonary disease (COPD)
Adoption by American Thoracic Society.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: December 31, 1999
Contact: practice@apta.org
Content Type: Test & Measure
You Might Also Like...
CPG
The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2020, Version 2.62Oct 1, 2020
The COPDX Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2019 (Vers. 2.59)
CPG
Chronic Obstructive Pulmonary Disease [Updated]Jul 1, 2020
This guideline provides recommendations related to the management of patients with chronic COPD including treatment of mild to moderate acute exacerbations.
CPG
Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management [NG115]Jul 26, 2019
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (including emphysema and chronic bronchitis) in people aged